Navigation Links
PharmD in Medical News

Diplomat Specialty Pharmacy Promotes Rinku A. Patel, PharmD to Vice President, Pharmacy Strategy

SWARTZ CREEK, Mich., June 2 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced the promotion of Dr. Rinku A. Patel to Vice President, Pharmacy Strategy. Patel was previously Diplomat's Director of Pharmacy Development and Operations. Patel's new role will encompass 3 main areas: ...

Actress and Mom Alison Sweeney Teams Up With the American Pharmacists Association to Help Fellow Allergy Sufferers Find Relief This Spring

...encourage sufferers who have questions about nasal congestion products or how to access these products to ask their pharmacist," said Michael Negrete, pharmd of the American Pharmacists Association. "Many people are unaware that some of the oral decongestant medicines they have relied on for years are still...

Prime Pharmacists Recognized by the Journal of Managed Care Pharmacy

...s clinical pharmacists, Patrick Gleason, PharmD, FCCP, BCPS, Cathy Starner, pharmd and Jeremy Schafer, pharmd were awarded the Journal of Managed Care Pharmacy (JMCP) Award of Excellenc...

Clearing the 'fog'

...kill the tumor, not if they cause a cognitive deficiency, like memory loss." Walker and Raffa decided to fill that void. Two years ago, Walker and pharmd student John Foley, set out to see if certain chemotherapeutic agents caused memory and learning deficits in mice. They tested two older drugs commonl...

CuraGen to Present at the Rodman & Renshaw Annual Global Investment Conference

...ragen.com . CRGN-G Contacts: Sean Cassidy Vice President and Chief Financial Officer scassidy@curagen.com (203) 871-4400 Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen Reports First Quarter 2008 Financial Results

...ss release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CURAGEN CORPORATION AND SUBSIDIARY CONDENSE...

Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine

...after 6 months. This study adds to the current literature on the economic value of comprehensive pain programs. Investigators: Julie L. Cunningham, pharmd Mayo Clinic, Rochester, MN 55902 Jeffrey D. Rome Mayo Clinic, Rochester, MN 55905 Cynthia O. Townsend Mayo Clinic, Rochester, MN 55905 Jennifer L. Ker...

CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA

... or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-P Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 ...

Weight-based dosing of ribavirin improves outcomes for patients with hepatitis C

...e fundamental basis for the impaired responsiveness in this population, they say. In an accompanying editorial, Steven-Huy Han, MD and Jason Smith, pharmd of Los Angeles, report that this study adds significantly to our understanding of interferon therapy in African American patients. It will change the ...
PharmD in Medical Technology

SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts

... on Addictions, University at Buffalo , Buffalo, NY Isabel Burk, MS Director of The Health Network, New York, NY Jeanna M. Marraffa, pharmd Clinical Toxicologist, Upstate New York Poison Center, Assistant Professor, SUNY Upstate Medical University , Syracuse, NY Phil Buckenmeyer,...

CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma

... otherwise. CRGN-P Contacts: Sean Cassidy Vice President and Chief Financial Officer scassidy@curagen.com (203) 871-4400 Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008

...ragen.com . CRGN-F Contacts: Sean Cassidy Vice President and Chief Financial Officer scassidy@curagen.com (203) 871-4400 Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma

...e or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-P Contact: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE

...rmation, future events or otherwise. Contacts: Sean Cassidy Vice President and Chief Financial Officer scassidy@curagen.com Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 CRGN-F - FINANCIAL TABLES ATTACHED - ...

CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer

...e or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-P Contact: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma

...s release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contacts: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 CRGN-P ...

CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma

...ss release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CRGN-P ...

CuraGen Advances CR011-vcMMAE into Phase II

...ss release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 CRGN-P ...

CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference

...ress release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CRGN-P ...
PharmD in Biological Technology

Premier Research Names Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance

PHILADELPHIA, May 26 /PRNewswire/ -- Premier Research Group Limited, the international pharmaceutical services company, announces the appointment of Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance. In this position, he will lead the global pharmacovigilance team ensuring th...

Diplomat Specialty Pharmacy Hires Rinku A. Patel, PharmD as Director of Pharmacy Development and Operations

SWARTZ CREEK, Mich., Nov. 3 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced that Dr. Rinku A. Patel has joined the company's executive management team. Dr. Patel will serve as Director of Pharmacy Development and Operations. She will be responsible for the management and developmen...

L&M Healthcare Communications, LLC, Hires Scott Karasinski, PharmD

Scott Karasinski, PharmD to Run Medical Services Department of the Expanding Independent Medical Education Agency MOUNTAINSIDE, N.J., Feb. 5 /PRNewswire/ -- L&M Healthcare Communications announces the appointment of Scott Karasinski, PharmD to the position of Vice President, Sci...

EPI-Q, Inc. Expands Capabilities with Addition of Anthony Vita, MD, MPH and Peter Herout, PharmD

OAK BROOK, Ill., Nov. 5 /PRNewswire/ -- EPI-Q, Inc., a consulting firm providing outcomes research and health economics services to the global biopharmaceutical and healthcare industries, announces the addition of Anthony J. Vita, MD, MPH and Peter Herout, PharmD to their team of clinical prof...

CuraGen Sells Ownership of Belinostat to TopoTarget A/S

... or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-P Contacts: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

Major Medical Journal Reports Higher Success, Fewer Complications and Lower Cost Treating DVT With Trellis(R) Isolated Thrombolysis Compared With Catheter-Directed Thrombolysis

...me required for follow-up monitoring in a costly critical care unit compared with CDT patients. The study, which was authored by Daniel E. Hilleman, pharmd (Department of Pharmacy Practice, Creighton University School of Pharmacy, Omaha, NE) and Mahmood K. Razavi, MD (Department of Vascular and Interventi...

CuraGen to Present at the BIO CEO & Investor Conference

...orporation is headquartered in Branford, Connecticut. For additional information please visit http://www.curagen.com . Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CRGN-G ...

CuraGen Reports Fourth Quarter and Year End 2007 Financial Results

... release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CURAGEN CORPORATION AND SUBSIDIARY CONDE...

CuraGen Corporation Receives Notification from NASDAQ

... or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-F Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 ...

CuraGen Corporation Announces Appointment of Sean Cassidy as CFO

... or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-G Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 ...
Other Tags
(Date:9/3/2014)... CA (PRWEB) September 03, 2014 AttorneyOne.com, a ... the latest information from the FDA on Pedigree nutrition ... August 26, that 22 bags of Pedigree Adult Complete Nutrition ... the possible presence of a foreign material. The reason for ... fragments, which could have entered the packages during the production ...
(Date:9/3/2014)... An inspiring story of the importance ... the season finale of “Extreme Weight Loss” Season Four. ... daughter from Highlands Ranch, Colo. who have a strained ... pounds. Their challenge is to team up to lose ... non-competitive approach to weight loss transformations, “Extreme Weight Loss” ...
(Date:9/3/2014)... September 03, 2014 Pwnie Express today ... cutting edge Pwn Plug, the R3, an inconspicuous pentesting ... of use at remote locations at a fraction of ... Pwnie Express is the only company to assess wired ... Plug R3 is a next-generation penetration testing device in ...
(Date:9/3/2014)... "What can you say about a sixteen-year-old girl who ... Eight in the Margaret of Greenwich (R) Young Adult ... Books, Inc . These novels narrate the lives of a ... in America. , In this thriller, learning geometry becomes the ... student’s murder plot. Her fears increase when Erika, the only ...
(Date:9/2/2014)... dry eye disease include the sensation of grit in ... disturbance. The causes are poorly understood., The researchers base ... 87 (average age 57) from the TwinsUK cohort, drawn ... London., This cohort is widely regarded as representative of ... look at a wide range of diseases and genetic ...
Breaking Medicine News(10 mins):Health News:Pedigree Adult Complete Nutrition for Dogs Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:“Extreme Weight Loss”: Jeff and Juliana’s Journey begin at the University of Colorado Anschutz Health and Wellness Center 2Health News:Pwnie Express Releases Next Generation Penetration Testing Device: The Pwn Plug R3 2Health News:Pwnie Express Releases Next Generation Penetration Testing Device: The Pwn Plug R3 3Health News:Pwnie Express Releases Next Generation Penetration Testing Device: The Pwn Plug R3 4Health News:Town Locked Down After Bombing and Murders in "Margaret and Hillary" - New Book Eight in the Margaret of Greenwich(R) Young Adult Series by R. L. Rhyse 2Health News:Around 1 in 10 UK women has dry eye disease, requiring artificial tears 2
(Date:9/2/2014)... lithographic limestone is well known as a result ... area (for example, Archaeopteryx). Now, for the first ... French equivalent of these outcrops - discoveries which ... water treader. , Despite the abundance of fossils ... been obtained from the Late Kimmeridgian equivalents of ...
(Date:9/2/2014)... stride; others are done in by it. New research ... this so-called stress gap in mice with very similar ... to better understand the development of psychiatric disorders such ... has unique experiences as it goes through its life. ... the expression of genes, and as a result, affect ...
(Date:9/1/2014)... U.S. has improved steadily in recent yearsspurred in large ... remains poor and disparities continue to widen among socioeconomic ... Harvard School of Public Health (HSPH). , "The study ... extensive efforts by many groups and individuals to improve ... also indicates that these efforts need to be expanded," ...
Breaking Biology News(10 mins):Exceptionally well preserved insect fossils from the Rhône Valley 2Discovery hints at why stress is more devastating for some 2Discovery hints at why stress is more devastating for some 3Quality of US diet shows modest improvement, but overall remains poor 2Quality of US diet shows modest improvement, but overall remains poor 3
Other Contents